PGHH.NS
Procter & Gamble Hygiene and Health Care Limited [PGHH.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PGHH.NS Stock Summary
Top 10 Correlated ETFs
PGHH.NS
Top 10 Correlated Stocks
PGHH.NS
In the News
PGHH.NS Financial details
Company Rating
Strong Buy
Market Cap
517.87B
Income
7.56B
Revenue
39.96B
Book val./share
324.21
Cash/share
225.55
Dividend
185
Dividend %
1.08%
Employees
432
Optionable
No
Shortable
Yes
Earnings
29 Jan 2024
P/E
75.74
Forward P/E
-
PEG
24.21
P/S
13.91
P/B
-
P/C
70.69
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
232.85
EPS next Y
-
EPS next Q
-
EPS this Y
17.78%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
10.1%
Revenue last 5Y
5.82%
Revenue Q/Q
-0.36%
EPS Q/Q
8.63%
-
-
-
-
SMA20
1.15%
SMA50
-5.89%
SMA100
-11.06%
Inst Own
-
Inst Trans
-
ROA
-
ROE
160%
ROC
-
Gross Margin
58%
Oper. Margin
23%
Profit Margin
18%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
13362.0-19250.0
52W High
-17.18%
52W Low
+19.32%
RSI
46
Rel Volume
0.16
Avg Volume
9.65K
Volume
1.59K
Perf Week
-1.95%
Perf Month
-0.54%
Perf Quarter
-5.43%
Perf Half Y
-8.09%
-
-
-
-
Beta
0.182
-
-
Volatility
115.03%, 357.69%
Prev Close
-0.83%
Price
15943.35
Change
0.18%
PGHH.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
| Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 906.47 | 923.74 | 1.1K | 1.17K | 1.2K | |
| Net income per share | 129.12 | 133.42 | 200.79 | 177.37 | 208.91 | |
| Operating cash flow per share | 126.87 | 146.04 | 265.9 | 176.55 | 254.39 | |
| Free cash flow per share | 121.91 | 130.32 | 256.16 | 161.21 | 240.7 | |
| Cash per share | 162.69 | 272.34 | 211.16 | 196.93 | 311.38 | |
| Book value per share | 280.05 | 356.7 | 220.04 | 227.22 | 291.44 | |
| Tangible book value per share | 280.05 | 356.7 | 220.04 | 227.22 | 291.44 | |
| Share holders equity per share | 280.05 | 356.7 | 220.04 | 227.22 | 291.44 | |
| Interest debt per share | 2.33 | 3.42 | 2.95 | 5.02 | 4.75 | |
| Market cap | 349.65B | 329.53B | 431.96B | 433.97B | 464.98B | |
| Enterprise value | 344.42B | 320.74B | 425.52B | 427.77B | 455.38B | |
| P/E ratio | 83.42 | 76.09 | 66.27 | 75.38 | 68.57 | |
| Price to sales ratio | 11.88 | 10.99 | 12.1 | 11.44 | 11.91 | |
| POCF ratio | 84.9 | 69.51 | 50.05 | 75.72 | 56.31 | |
| PFCF ratio | 88.36 | 77.9 | 51.95 | 82.93 | 59.51 | |
| P/B Ratio | 38.46 | 28.46 | 60.48 | 58.84 | 49.15 | |
| PTB ratio | 38.46 | 28.46 | 60.48 | 58.84 | 49.15 | |
| EV to sales | 11.7 | 10.7 | 11.92 | 11.28 | 11.66 | |
| Enterprise value over EBITDA | 50.76 | 47.44 | 45.08 | 49.47 | 50.09 | |
| EV to operating cash flow | 83.63 | 67.66 | 49.3 | 74.64 | 55.15 | |
| EV to free cash flow | 87.03 | 75.82 | 51.17 | 81.75 | 58.28 | |
| Earnings yield | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | |
| Free cash flow yield | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | |
| Debt to equity | 0 | 0 | 0 | 0.01 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | -0.77 | -1.3 | -0.68 | -0.72 | -1.06 | |
| Current ratio | 1.66 | 2.23 | 1.34 | 1.32 | 1.38 | |
| Interest coverage | 104.66 | 97.28 | 139.77 | 70.53 | 71.2 | |
| Income quality | 0.68 | 0.8 | 0.99 | 0.73 | 0.98 | |
| Dividend Yield | 0.01 | 0.01 | 0.03 | 0.01 | 0.01 | |
| Payout ratio | 0.75 | 0.43 | 1.69 | 0.99 | 0.69 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.12 | -0.02 | -0.02 | 0.14 | 0.15 | |
| Capex to operating cash flow | -0.04 | -0.11 | -0.04 | -0.09 | -0.05 | |
| Capex to revenue | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 | |
| Capex to depreciation | -0.32 | -1.07 | -0.66 | -0.94 | -0.76 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 901.99 | 1.03K | 997.05 | 952.25 | 1.17K | |
| ROIC | 0.43 | 0.37 | 0.89 | 0.77 | 0.69 | |
| Return on tangible assets | 0.29 | 0.23 | 0.39 | 0.4 | 0.37 | |
| Graham Net | 50.84 | 142.7 | 9.56 | -7.65 | 29.07 | |
| Working capital | 4.33B | 7.33B | 2.82B | 2.76B | 4.11B | |
| Tangible asset value | 7.13B | 11.99B | 7.52B | 4.97B | 6.26B | |
| Net current asset value | 3.68B | 6.58B | 1.99B | 1.9B | 3.04B | |
| Invested capital | 0 | 0 | 0 | 0.01 | 0 | |
| Average receivables | 3.25B | 2.7B | 1.91B | 2.01B | 2.18B | |
| Average payables | 4.77B | 5.4B | 6.43B | 7.66B | 8.75B | |
| Average inventory | 1.64B | 2.04B | 2.27B | 2.42B | 2.27B | |
| Days sales outstanding | 42.68 | 23.89 | 19 | 20.86 | 20.56 | |
| Days payables outstanding | 142.8 | 151.71 | 207.17 | 161.24 | 213.13 | |
| Days of inventory on hand | 53.04 | 58.55 | 68.49 | 48.47 | 48.24 | |
| Receivables turnover | 8.55 | 15.28 | 19.21 | 17.49 | 17.75 | |
| Payables turnover | 2.56 | 2.41 | 1.76 | 2.26 | 1.71 | |
| Inventory turnover | 6.88 | 6.23 | 5.33 | 7.53 | 7.57 | |
| ROE | 0.46 | 0.37 | 0.91 | 0.78 | 0.72 | |
| Capex per share | -4.96 | -15.72 | -9.73 | -15.34 | -13.69 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q2
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 349.4 | 271.52 | 261.46 | 349.69 | 348.37 | |
| Net income per share | 63.91 | 50.84 | 46.59 | 64.91 | 70.51 | |
| Operating cash flow per share | 8.88 | 8.98 | 13.84 | 8.81 | 8.79 | |
| Free cash flow per share | 8.88 | 8.98 | 13.84 | 8.81 | 8.79 | |
| Cash per share | 297.05 | 291.35 | 311.37 | 301.3 | 225.55 | |
| Book value per share | 273.85 | 273.88 | 291.43 | 291.46 | 324.21 | |
| Tangible book value per share | 273.85 | 0 | 291.43 | 0 | 324.21 | |
| Share holders equity per share | 273.85 | 273.88 | 291.43 | 291.46 | 324.21 | |
| Interest debt per share | 2.15 | 1.1 | 2.17 | 0.58 | 1.89 | |
| Market cap | 471.88B | 432.99B | 465B | 582.71B | 563.47B | |
| Enterprise value | 462.59B | 442.44B | 455.4B | 592.49B | 556.62B | |
| P/E ratio | 56.86 | 65.6 | 76.86 | 69.14 | 61.54 | |
| Price to sales ratio | 41.6 | 49.13 | 54.79 | 51.34 | 49.82 | |
| POCF ratio | 1.64K | 1.48K | 1.03K | 2.04K | 1.98K | |
| PFCF ratio | 1.64K | 1.48K | 1.03K | 2.04K | 1.98K | |
| P/B Ratio | 53.08 | 48.71 | 49.15 | 61.6 | 53.54 | |
| PTB ratio | 53.08 | 48.71 | 49.15 | 61.6 | 53.54 | |
| EV to sales | 40.78 | 50.2 | 53.66 | 52.2 | 49.22 | |
| Enterprise value over EBITDA | 154.3 | 270.26 | 202.41 | 197.06 | 171.1 | |
| EV to operating cash flow | 1.61K | 1.52K | 1.01K | 2.07K | 1.95K | |
| EV to free cash flow | 1.61K | 1.52K | 1.01K | 2.07K | 1.95K | |
| Earnings yield | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | -3.1 | 5.78 | -4.27 | 3.25 | -2.11 | |
| Current ratio | 1.47 | 0 | 1.38 | 0 | 1.51 | |
| Interest coverage | 73.94 | 41.77 | 66.49 | 151.51 | 121.98 | |
| Income quality | 0.14 | 0.18 | 0.3 | 0.14 | 0.12 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.11 | 0 | 0.15 | 0 | 0.14 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0.02 | 0 | 0 | |
| Graham number | 627.52 | 559.73 | 552.72 | 652.43 | 717.18 | |
| ROIC | 0.23 | 0.19 | 0.15 | 0.22 | 0.22 | |
| Return on tangible assets | 0.12 | 0 | 0.08 | 0 | 0.12 | |
| Graham Net | 45.3 | 291.35 | 29.06 | 301.3 | 42.86 | |
| Working capital | 4.73B | 9.46B | 4.11B | 9.78B | 5.45B | |
| Tangible asset value | 6.75B | 0 | 6.26B | 0 | 7.32B | |
| Net current asset value | 3.76B | 9.46B | 3.04B | 9.78B | 4.36B | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 1.3B | 1.3B | 1.1B | 1.1B | 3.25B | |
| Average payables | 4.63B | 4.63B | 4.86B | 4.86B | 4.68B | |
| Average inventory | 1.03B | 1.03B | 1.1B | 1.1B | 927.25M | |
| Days sales outstanding | 20.64 | 0 | 23.33 | 0 | 51.8 | |
| Days payables outstanding | 171.47 | 0 | 242.92 | 0 | 186.79 | |
| Days of inventory on hand | 38.18 | 0 | 54.98 | 0 | 37.01 | |
| Receivables turnover | 4.36 | 0 | 3.86 | 0 | 1.74 | |
| Payables turnover | 0.52 | 0 | 0.37 | 0 | 0.48 | |
| Inventory turnover | 2.36 | 0 | 1.64 | 0 | 2.43 | |
| ROE | 0.23 | 0.19 | 0.16 | 0.22 | 0.22 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
PGHH.NS Frequently Asked Questions
What is Procter & Gamble Hygiene and Health Care Limited stock symbol ?
Procter & Gamble Hygiene and Health Care Limited is a IN stock and trading under the symbol PGHH.NS
What is Procter & Gamble Hygiene and Health Care Limited stock quote today ?
Procter & Gamble Hygiene and Health Care Limited stock price is $15943.35 today.
Is Procter & Gamble Hygiene and Health Care Limited stock public?
Yes, Procter & Gamble Hygiene and Health Care Limited is a publicly traded company.
Company Profile
- Volume Average 9.65K
- Market Capitalization 517.87B
- Employee 432
- CEO Mr. Lalgudi Viswanathan Vaidyanathan
- Headquarters Mumbai,IN
- IPO Date 2002-08-12
-
Website
https://in.pg.com 
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. The company provides health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also offers baby care products comprising nappies, pants, and baby wipes; laundry products; hair care products; home care products; and oral care products. The company offers its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brand names. It sells its products through retail operations, including mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited is a subsidiary of Procter & Gamble Overseas India BV.
